España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Canntab Therapeutics
CTABF
OTCEM
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.000001
Last update: Dec 31, 7:00 PM
Get Report
Comment
Canntab Therapeutics (CTABF) Forecast
News
Earnings
Canntab Therapeutics (CTABF) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Canntab Therapeutics (OTC:CTABF) Stock
Canntab Therapeutics Stock (OTC: CTABF)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, August 05, 2022
Canopy Growth & Other Cannabis Operators Just Made Some Key Executive Changes You Should Know About
Jelena Martinovic
Wednesday, March 23, 2022
Canntab Therapeutics Signs Affiliate Agreement With OnPharm-United
Vuk Zdinjak
Monday, February 07, 2022
Canntab Therapeutics Teams Up With First Nations Growers To Support Indigenous Peoples In Canada Amid Opiate & Illicit Drug Crisis
Jelena Martinovic
Wednesday, February 02, 2022
Canntab Closes $1.31M Convertible Debenture Private Placement, Corporate Secretary Resigns
Nina Zdinjak
Thursday, January 20, 2022
Canntab Launches E-Commerce Platform, Enabling Canadians Access To THC & CBD In Pill Form
Nina Zdinjak
Monday, January 10, 2022
Levitee Labs Teams Up With Canntab Therapeutics, Offer Cannabinoid Products As Alternatives To Opioids
Nina Zdinjak
Canntab Therapeutics Completes First Shipment Of THC Tablets To Ontario Cannabis Stores
Jelena Martinovic
Friday, August 21, 2020
Cannabis Movers & Shakers: Aleafia, Clever Leaves, Boldt Runners, Nabis, Canntab, Leafly, CannaSafe
Jelena Martinovic
Monday, February 24, 2020
Canntab Obtains Health Canada Cannabis Research License
Nina Zdinjak
Thursday, December 12, 2019
Stocks That Hit 52-Week Lows On Thursday
Lisa Levin
Monday, December 02, 2019
Stocks That Hit 52-Week Lows On Monday
Lisa Levin
Monday, August 05, 2019
New 52-Week Lows For Monday Morning
Lisa Levin
